Perioperative Management of Colorectal Cancer Patients Infected With COVID-19: a Multicenter Prospective Cohort Study.

Naval Military Medical University

Status

Not yet enrolling

Conditions

Surgical Procedure, Unspecified

Colorectal Cancer

Treatments

Procedure: Timing of colorectal cancer surgery

Study type

Observational

Funder types

Other

Identifiers

NCT05682898

WeiZhang

Details and patient eligibility

About

This trial is a multicenter prospective cohort study to explore timing of colorectal cancer surgery after COVID-19 infection so that can assist clinicians and patients. Currently, there is less evidence on perioperative outcomes after COVID-19 vaccination and the omicron variant. Therefore, it is necessary to update previously published consensus which recommends that patients should avoid elective surgery within 7 weeks of COVID-19 infection remain, unless the benefits of doing so exceed the risk of waiting. Aiming at the above problems, we plan to carry out a multicenter prospective cohort study to develop perioperative management according patients' different conditions.

Enrollment

300 estimated patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

undergoing colorectal cancer surgery
infected with COVID-19 but nucleic acid test result is negative
the patients compliance is good
signed the consents voluntarily

Exclusion criteria

undergoing emergency surgery(intestinal obstruction, intestinal perforation, intestinal hemorrhage, et al.)
The patients' situations which judged by situations is not suitable to participate in the clinical trial